Puma Biotechnology, Inc. Profile Avatar - Palmy Investing

Puma Biotechnology, Inc.

Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the pati…

Biotechnology
US, Los Angeles [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Puma Biotechnology, Inc. has no acquisition track records yet.

M&A Deals · History

Puma Biotechnology, Inc. has no acquisition track records yet.

End of PBYI's Analysis
CIK: 1401667 CUSIP: 74587V107 ISIN: US74587V1070 LEI: - UEI: -
Secondary Listings
PBYI has no secondary listings inside our databases.